Genetic and epigenetic molecular patterns that promote prostate carcinogenesis are the loss of PTEN, amplification and overexpression of MYC, fusion between TMPRSS2 and ERG, inactivation of RB and P53, and dysregulation of Krüppel-like factor 5 (KLF5) [136]. This evidence concerns the gene KLF5 and medical procedure.